Pentoxifylline

FDA Drug Profile — Pentoxifylline, TRENTAL

Pentoxifylline is listed in the FDA National Drug Code directory with 9 NDC codes, marketed under brand names including Pentoxifylline, TRENTAL. Available dosage forms: tablet, extended release, powder, tablet.

Drug details

Generic Name
Pentoxifylline
Brand Names
Pentoxifylline, TRENTAL
Application Number
ANDA074425
Sponsor
Rising Pharma Holdings, Inc.
NDC Codes
9
Dosage Forms
TABLET, EXTENDED RELEASE, POWDER, TABLET
Routes
ORAL
Active Ingredients
PENTOXIFYLLINE

Indications and Usage

INDICATIONS & USAGE Pentoxifylline extended-release tablets are indicated for the treatment of patients with intermittent claudication on the basis of chronic occlusive arterial disease of the limbs. Pentoxifylline extended-release tablets can improve function and symptoms but is not intended to replace more definitive therapy, such as surgical bypass, or removal of arterial obstructions when treating peripheral vascular disease.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.